Shopping Cart 0
Cart Subtotal
USD 0

OriGene Technologies Inc-Medical Equipment-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

OriGene Technologies Inc (OriGene) is a life science company that develops, manufactures and sells genome research and diagnostic products. The company's products include cDNA clones, qPCR reagents, plasmid purification, HuSH shRNA, siRNA, miRNA, transfection reagent, precisionshuttling kits, proteins antibodies, IHC products, assays and human tissues, among others. It provides services such as gene synthesis, custom cloning, custom shRNA, custom protein service, antibody service, assay development and stable cell line development. OriGene provides research in the areas of cancer biomarker research, pathology IHC, stem cell research, ion channels, and protein kinase. The company offers products and services to pharmaceutical and biotechnology companies and academic research institutes. It distributes its products in Asia, Europe and North American countries. OriGene is headquartered in Rockville, Maryland, the US.

OriGene Technologies Inc-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

OriGene Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

OriGene Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

OriGene Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

OriGene Technologies Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8

OriGene Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

OriGene Technologies Inc, Medical Equipment, Deal Details 10

Asset Purchase 10

Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 10

Partnerships 11

OriGene Technologies Enters into Licensing Agreement with Diadexus 11

SDIX Enters Into Licensing Agreement With BD Diagnostic 12

Entia Biosciences Enters Into Co-Development Agreement With Biocheck 13

OriGene Technologies Enters Into Co-Development Agreement With Centre of Excellence for Prevention of Organ Failure 14

DuPont Enters Into Co-Development Agreement With OligoCo 15

Asset Transactions 16

Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 16

Romer Labs Completes Acquisition Of Food Safety And GMO Business Of Strategic Diagnostics For US$13.5 Million 17

Acquisition 18

OriGene Technologies Acquires BioCheck 18

OriGene Technologies Acquires Beijing Zhongshan Golden Bridge Biotechnology, Pathology Testing Products Provider 19

OriGene Technologies Inc-Key Competitors 21

Key Employees 22

Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 25

Other Significant Developments 25

Jan 07, 2016: OriGene Technologies Awarded Phase II SBIR Contract to Develop High-Affinity, Anti-Peptide Monoclonal Antibodies for SISCAPA Assays 25

Appendix 26

Methodology 26

About GlobalData 26

Contact Us 26

Disclaimer 26


List Of Figure

List of Figures

OriGene Technologies Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

OriGene Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

OriGene Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

OriGene Technologies Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

OriGene Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

OriGene Technologies Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6

OriGene Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

OriGene Technologies Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8


List Of Table

List of Tables

OriGene Technologies Inc, Medical Equipment, Key Facts 1

OriGene Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

OriGene Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

OriGene Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

OriGene Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

OriGene Technologies Inc, Deals By Market, 2011 to YTD 2017 8

OriGene Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 10

OriGene Technologies Enters into Licensing Agreement with Diadexus 11

SDIX Enters Into Licensing Agreement With BD Diagnostic 12

Entia Biosciences Enters Into Co-Development Agreement With Biocheck 13

OriGene Technologies Enters Into Co-Development Agreement With Centre of Excellence for Prevention of Organ Failure 14

DuPont Enters Into Co-Development Agreement With OligoCo 15

Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 16

Romer Labs Completes Acquisition Of Food Safety And GMO Business Of Strategic Diagnostics For US$13.5 Million 17

OriGene Technologies Acquires BioCheck 18

OriGene Technologies Acquires Beijing Zhongshan Golden Bridge Biotechnology, Pathology Testing Products Provider 19

OriGene Technologies Inc, Key Competitors 21

OriGene Technologies Inc, Key Employees 22

OriGene Technologies Inc, Other Locations 23

OriGene Technologies Inc, Subsidiaries 23

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

OriGene Technologies Inc (OriGene) is a life science company that develops, manufactures and sells genome research and diagnostic products. The company's products include cDNA clones, qPCR reagents, plasmid purification, HuSH shRNA, siRNA, miRNA, transfection reagent, precisionshuttling kits, proteins antibodies, IHC products, assays and human tissues, among others. It provides services such as gene synthesis, custom cloning, custom shRNA, custom protein service, antibody service, assay development and stable cell line development. OriGene provides research in the areas of cancer biomarker research, pathology IHC, stem cell research, ion channels, and protein kinase. The company offers products and services to pharmaceutical and biotechnology companies and academic research institutes. It distributes its products in Asia, Europe and North American countries. OriGene is headquartered in Rockville, Maryland, the US.

OriGene Technologies Inc-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

OriGene Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

OriGene Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

OriGene Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

OriGene Technologies Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8

OriGene Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

OriGene Technologies Inc, Medical Equipment, Deal Details 10

Asset Purchase 10

Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 10

Partnerships 11

OriGene Technologies Enters into Licensing Agreement with Diadexus 11

SDIX Enters Into Licensing Agreement With BD Diagnostic 12

Entia Biosciences Enters Into Co-Development Agreement With Biocheck 13

OriGene Technologies Enters Into Co-Development Agreement With Centre of Excellence for Prevention of Organ Failure 14

DuPont Enters Into Co-Development Agreement With OligoCo 15

Asset Transactions 16

Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 16

Romer Labs Completes Acquisition Of Food Safety And GMO Business Of Strategic Diagnostics For US$13.5 Million 17

Acquisition 18

OriGene Technologies Acquires BioCheck 18

OriGene Technologies Acquires Beijing Zhongshan Golden Bridge Biotechnology, Pathology Testing Products Provider 19

OriGene Technologies Inc-Key Competitors 21

Key Employees 22

Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 25

Other Significant Developments 25

Jan 07, 2016: OriGene Technologies Awarded Phase II SBIR Contract to Develop High-Affinity, Anti-Peptide Monoclonal Antibodies for SISCAPA Assays 25

Appendix 26

Methodology 26

About GlobalData 26

Contact Us 26

Disclaimer 26


List Of Figure

List of Figures

OriGene Technologies Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

OriGene Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

OriGene Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

OriGene Technologies Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

OriGene Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

OriGene Technologies Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6

OriGene Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

OriGene Technologies Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8


List Of Table

List of Tables

OriGene Technologies Inc, Medical Equipment, Key Facts 1

OriGene Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

OriGene Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

OriGene Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

OriGene Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

OriGene Technologies Inc, Deals By Market, 2011 to YTD 2017 8

OriGene Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 10

OriGene Technologies Enters into Licensing Agreement with Diadexus 11

SDIX Enters Into Licensing Agreement With BD Diagnostic 12

Entia Biosciences Enters Into Co-Development Agreement With Biocheck 13

OriGene Technologies Enters Into Co-Development Agreement With Centre of Excellence for Prevention of Organ Failure 14

DuPont Enters Into Co-Development Agreement With OligoCo 15

Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 16

Romer Labs Completes Acquisition Of Food Safety And GMO Business Of Strategic Diagnostics For US$13.5 Million 17

OriGene Technologies Acquires BioCheck 18

OriGene Technologies Acquires Beijing Zhongshan Golden Bridge Biotechnology, Pathology Testing Products Provider 19

OriGene Technologies Inc, Key Competitors 21

OriGene Technologies Inc, Key Employees 22

OriGene Technologies Inc, Other Locations 23

OriGene Technologies Inc, Subsidiaries 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com
chat_bubbleLet's Chat